Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Linda Kaplan who wrote (5742)	9/29/1998 7:49:00 PM
From: dino	Read Replies (1) \| Respond to of 7041

As usual Linda, you put a negative spin on something. You must be the life of every party. Your argument is one that will probably be temporary in nature. If Vasomax can maintain a small market share in Mexico, then one can assume it will be able to do the same in the U.S. That of course is all Zonagen has said regarding this product and this would translate into a much higher share price than today's levels. Individuals with mild ED will try Vasomax first because of its faster action and less side effects. If it does not work, then they will move to Viagra. Linda, I suppose you will type some negative spin suggesting that couples are not ready in 15 minutes and the 60 minutes is more desirable. Or maybe you will suggest that people enjoy the blue vision and pounding headaches after using Viagra's product. Perhaps you should call that drug store in Mexico again and tell us that Vasomax isn't selling............. Soon enough, the speculation and lies will be pushed aside as they have been repeatedly in the past. Enjoy your evening.